Genentech, a Member of the Roche Group

12:00 PM - 12:15 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 104B
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. Today, as a member of the Roche Group, we remain dedicated to pursuing breakthrough research, developing life-changing medicines, unlocking advances in data and technology, and partnering across society to take on systemic issues that stand in the way of better healthcare for all.
We lead change in our industry and advance science for the greater good. We embrace diversity and inclusion to drive innovation, improve outcomes, and create more equitable healthcare access. And every day, we lean into the biggest challenges in science, medicine, technology, and beyond to deliver patient-centered healthcare that improves life for every person.
SIX Swiss Exchange
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Multiple Therapeutics
Lead Product in Development:
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Executive Director, Research Technologies, Pharma Partnering